StockData
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc. (SLS) stock

SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$19.15+11.68 (+156.36%)

Close on Nov 17, 2026Market cap $3.87BP/E –Yield –

SELLAS Life Sciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

SELLAS Life Sciences's price to book ratio was 12.4× on Nov 11, 2026, against 4.4× a year earlier. Over the last 5 years it ranged from 2.1× to 25.6×, with a median of 6.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202612.4×+2.0
2025Dec 31, 202510.3×+6.1
2024Dec 31, 20244.2×−1.5
2023Oct 31, 20235.7×+1.8
2022Dec 30, 20223.9×+0.6
2021Dec 31, 20213.3×−3.6
2020Dec 31, 20206.9×+5.1
2019Dec 31, 20191.8×+0.5
2018Dec 31, 20181.4×−21.1
2017Dec 29, 201722.5×−3.6
2016Dec 30, 201626.1×−195.1
2015Dec 31, 2015221.2×+42.9
2014Dec 31, 2014178.3×−272.6
2013Dec 31, 2013450.9×+231.9
2012Dec 31, 2012219.1×+90.3
2011Dec 30, 2011128.7×–

More SELLAS Life Sciences figures

See a number that looks wrong?